COMPARISON BETWEEN HUMAN MENOPAUSAL GONADOTROPIN (HMG) AND PURIFIED FSH IN THE TREATMENT OF WOMEN WITH POLYCYSTIC OVARIAN DISEASE (PCO)

被引:0
|
作者
BLUNT, SM [1 ]
RUDD, BT [1 ]
HABOUBI, N [1 ]
BUTT, WR [1 ]
机构
[1] BIRMINGHAM & MIDLAND HOSP WOMEN,DEPT CLIN ENDOCRINOL,BIRMINGHAM B11 4HL,W MIDLANDS,ENGLAND
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:226 / 226
页数:1
相关论文
共 50 条
  • [1] TREATMENT OF POLYCYSTIC OVARY SYNDROME (PCO) WITH PURE FOLLICLE-STIMULATING-HORMONE (FSH) OR HUMAN MENOPAUSAL GONADOTROPINS (HMG)
    MCFAUL, PB
    TRAUB, AI
    SHERIDAN, B
    LESLIE, H
    [J]. BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1988, 95 (05): : 534 - 534
  • [2] PHARMACODYNAMICS OF HUMAN MENOPAUSAL GONADOTROPIN (HMG) AND FOLLICLE-STIMULATING-HORMONE (FSH) - THE IMPORTANCE OF THE FSH CONCENTRATION IN INITIATING FOLLICULAR-GROWTH IN POLYCYSTIC OVARY-LIKE DISEASE
    VANWEISSENBRUCH, MM
    SCHOEMAKER, HC
    DREXHAGE, HA
    SCHOEMAKER, J
    [J]. HUMAN REPRODUCTION, 1993, 8 (06) : 813 - 821
  • [3] COMPARISON BETWEEN HUMAN URINARY FOLLICLE-STIMULATING-HORMONE AND HUMAN MENOPAUSAL GONADOTROPIN TREATMENT IN POLYCYSTIC OVARY
    VENTUROLI, S
    PARADISI, R
    FABBRI, R
    MAGRINI, O
    PORCU, E
    FLAMIGNI, C
    [J]. OBSTETRICS AND GYNECOLOGY, 1984, 63 (01): : 6 - 11
  • [4] COAGULATION CHANGES FOLLOWING OVARIAN STIMULATION WITH HUMAN MENOPAUSAL GONADOTROPIN (HMG) AND HUMAN CHORIONIC GONADOTROPIN (HCG)
    PHILLIPS, LL
    GLADSTON.W
    WIELE, RV
    [J]. OBSTETRICS AND GYNECOLOGY, 1967, 29 (03): : 432 - &
  • [5] COMPARISON OF URINARY HUMAN FOLLICLE-STIMULATING-HORMONE AND HUMAN MENOPAUSAL GONADOTROPIN FOR OVARIAN STIMULATION IN POLYCYSTIC OVARIAN SYNDROME
    LARSEN, T
    LARSEN, JF
    SCHIOLER, V
    BOSTOFTE, E
    FELDING, C
    [J]. FERTILITY AND STERILITY, 1990, 53 (03) : 426 - 431
  • [6] DELINEATION OF MECHANISM OF INAPPROPRIATE SECRETION OF LH AND FSH IN POLYCYSTIC OVARIAN DISEASE (PCO)
    REBAR, R
    JUDD, HL
    RAKOFF, JS
    VANDENBERG, G
    NAFTOLIN, F
    YEN, SC
    [J]. GYNECOLOGIC INVESTIGATION, 1975, 6 (1-2): : 8 - 9
  • [7] The place of cotreatment with growth hormone and human menopausal gonadotropin (hMG) in ovarian stimulation
    Homburg, R
    BenRafael, Z
    [J]. JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 1996, 13 (05) : 371 - 373
  • [8] Does the Use of Highly Purified Human Menopausal Gonadotrophin (HP-HMG) Avoid Ovarian Hyperstimulation Syndrome (OHSS) in Polycystic Ovary (PCO) Patients in Assisted Reproduction (IVF/ICSI)?
    Elmahaishi, A.
    Elmahaishi, M. S.
    [J]. 18TH WORLD CONGRESS ON CONTROVERSIES IN OBSTETRICS, GYNECOLOGY & INFERTILITY (COGI), 2014, : 77 - 83
  • [9] COMPARISON OF OVARIAN RESPONSE IN THE SAME WOMEN WITH THE SAME OR DIFFERENT LOTS OF HUMAN MENOPAUSAL GONADOTROPIN
    DIAMOND, MP
    POLAN, ML
    BLANCHETTE, M
    MAZURE, CM
    DECHERNEY, AH
    LUNENFELD, B
    [J]. GYNECOLOGICAL ENDOCRINOLOGY, 1992, 6 (02) : 135 - 139
  • [10] Retrospective analysis of treatments with recombinant FSH and recombinant LH versus human menopausal gonadotropin in women with reduced ovarian reserve
    Renzini, Mario Mignini
    Brigante, Claudio
    Coticchio, Giovanni
    Dal Canto, Mariabeatrice
    Caliari, Ilaria
    Comi, Ruggero
    De Ponti, Elena
    Fadini, Rubens
    [J]. JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2017, 34 (12) : 1645 - 1651